Delivery Order SPE2DB20D1100-SPE2DB23FD4Z4
Award Date 9/7/23
Potential Completion Date 9/8/23
Potential Value $4.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,683.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of Restasis 0.05% eye emulsion. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 25, 2023 under the terms of the contract. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies...
- The Defense Logistics Agency awarded a $1,971.35 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 30 units of Restasis 0.05% eye emulsion. The place of performance will be in Conshohocken, Pennsylvania and all items are required to be delivered by October 19, 2023. No set-aside designation was applied to this order, which was issued under an existing vehicle managed by the Defense Logistics Agency to...
- The Defense Logistics Agency awarded a $4,518.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562052041 RESTASIS 0.05% eye emulsion in 30 single-use containers. Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by September 6, 2023 under the terms of this order issued against an existing DLA-wide supply contract vehicle. As a leading provider of pharmaceuticals and...
- The Defense Logistics Agency awarded a $7,368.09 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of 0.05% RESTASIS eye emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is scheduled to be completed between July 27-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for eye medication supports the DLA's mission to provide logistics...
- This firm fixed-price delivery order, valued at approximately $507, was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corporation to supply 30 units of Restasis 0.05% eye emulsion. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is to be completed between August 18-21, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency Troop Support Medical supports the...
- The Defense Logistics Agency awarded a $2,916.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561731290 RESTASIS 0.05% eye emulsion in 30 single-use containers. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance spans from August 7, 2023 through August 8, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...
- The Defense Logistics Agency awarded a $42,936.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561400107 RESTASIS 0.05% eye emulsion in 30 count bottles. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance spans from July 3 to July 5, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for RESTASIS, an ophthalmic...
- The Defense Logistics Agency awarded a $4,560.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Restasis 0.05% eye emulsion (30 count). The order, with an ultimate completion date of January 26, 2026, is a non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $13,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The prime contractor will deliver 30 units of the product to a location in Conshohocken, Pennsylvania by August 1, 2023 under the terms of the order. No additional details were provided regarding the solicitation or any overarching contract vehicle. The single award was made without a set-aside designation to Amerisourcebergen Drug Corporation...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,800.80 to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% RESTASIS eye emulsion. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from August 22 to August 23, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a specific eye medication supports DLA's mission to provide logistics support for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD4Z4Delivery Order
The Defense Logistics Agency awarded a $4,130.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of Restasis 0.05% eye emulsion. The prime contractor will deliver the requested pharmaceutical product to a facility located in Conshohocken, Pennsylvania. The order was awarded under an unspecified multiple award contract vehicle and will be funded by the Defense Logistics Agency to support the Department of Defense's medical supply needs. Performance is required between September 7-8, 2023. No set aside designation or subcontractors were identified.
Generated 12/23/23, 12:26 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/7/23 |